Agilent Technologies Inc.
This application note describes how a focused gradient is used to optimize the scale-up process from a 4.6 × 250 mm analytical column to a 50 × 243 mm preparative HPLC purification column.
Direct scale-up from analytical flow rates of 1.5 mL/min to preparative flow rates of 177 mL/min on a combined system poses several challenges: solvent delivery must be accurate at both low and high flow rates, and detection must span a wide dynamic range to cope with vastly different concentrations (1–5).
Agilent SD-1 Binary Purification System with Agilent Prep-C18 Scalar, 4.6 × 250 mm, 10 µm analytical column and Agilent Load & Lock preparative column, 50 × 243 mm, packed with 300 g of Agilent Prep-C18, 10 µm, at 1500 psi.
Formulas from the literature were used to scale-up the generic gradient profile from the analytical to preparative column (3,4). Taking dwell volume and column dead volume into consideration, the elution points of five standard compounds were determined using a linear elution gradient from 2 to 98% B within 16 min. The elution points of two adjacent peaks gave the start- and end-points of the focused gradients each with a slope of 2% B/min.
Figure 1: Generic and focused gradient applied to the standard calibration mixture and overlaid with a sample.
5 µL of sample were analyzed on the analytical column using the generic gradient profile. The two target compounds eluted within window #3, hence focused gradient #3 was used for purification. A resolution of 1.11 for the two compounds was still obtained with an injection volume of 40 µL equivalent to 18.7 mg of sample. For purification on the preparative column, the scale-up formula was used to calculate a final injection volume of 4500 µL (2.11 mg). The recovery level of the collected fractions was 85 and 89%, respectively.
The Agilent SD-1 Purification System is a combined analytical/preparative HPLC system that provides for straightforward scale-up from a 4.6 × 250 mm i.d. analytical column to a 50 × 243 mm i.d. self-packed Agilent Load & Lock column. A focused gradient facilitated increase of column load and reduced runtime and solvent consumption.
(1) J.W. Dolan, LCGCNorth Am. 24(5), 458–466 (2006).
(2) J.W. Dolan and L.R. Snyder, J. of Chromatography A 99, 21–34 (1998).
(3) D. Guillarme, D. Nguyen, S. Rudaz, and J.L. Veuthey, Eur.J. Pharm. Biopharm. 66, 475–482 (2007).
(4) D. Guillarme, D. Nguyen, S. Rudaz, and J.L. Veuthey, Eur.J. Pharm. Biopharm. 68, 430–440 (2008).
(5) L.R. Snyder, J.J. Kirkland, and J.W. Dolan, Introduction to Modern Liquid Chromatography (3rd Edition, Wiley, Hoboken, New Jersey, 2010), pp. 403–498.
(6) P. Penduff, Scale-up with the Agilent SD-1 Purification System Analytical and Preparative Runs on a Single System, Agilent publication number 5991-2012EN, 2013.
Agilent Technologies Inc.
5301 Stevens Creek Blvd., Santa Clara, CA 95051
tel. (800) 227-9770 (Directory)
Website: www.agilent.com/chem/purifyyourway
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.